Skip to main content

VantAI

VantAI develops computational models that enable programmable protein interactions, utilizing generative AI to enhance drug discovery processes. This technology addresses the challenge of accurately predicting molecular interactions, thereby accelerating the development of targeted therapeutics.

Traction 8/10
East New York, United States · HQ
Founded 2019637K+ followers
  • Artificial Intelligence
  • Biotechnology
Updated 7 months ago

Funding

Raised to date

$30MRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

across 1 round

Founders

1 founder

Alexander Goncearenco

Modulating protein-protein interactions to cure diseases and cancer

Product

Problem

Traditional drug discovery methods struggle to accurately predict and optimize protein-protein interactions, which are critical for developing targeted therapeutics. Accurately modeling these interactions at an atomic level is computationally intensive and often lacks the precision needed for effective drug design.

Solution

VantAI develops computational models leveraging generative AI to enable programmable protein interactions, enhancing the drug discovery process. Their integrated discovery platform utilizes three complementary technologies—inducers, modulators, and blockers—to unlock the full potential of proximity modulation. By using proprietary, large-scale structural data and NVIDIA GPUs on Google Cloud, VantAI aims to improve the accuracy of all-atom protein interaction prediction. This approach facilitates the design of novel therapeutics with enhanced specificity and efficacy.

Target Audience

VantAI's primary customers are pharmaceutical companies and research institutions involved in drug discovery and development, particularly those focused on targeted therapeutics and protein modulation.

Features

  • Generative AI-driven platform for predicting and optimizing protein-protein interactions
  • Integrated discovery platform with inducers, modulators, and blockers
  • Utilizes proprietary, large-scale structural data
  • Leverages NVIDIA H100 GPUs on Google Cloud for enhanced computational power
  • Focus on all-atom protein interaction prediction for increased accuracy
This profile is AI-generated and may contain inaccuracies.